Skip to content
Dr. Gaurang Ramesh

Home Articles

Microbiome learning path · Chapter 14

Gut bacteria and conditions of the brain

Parkinson’s disease, Alzheimer’s disease, multiple sclerosis and autism are four very different conditions. Each has been linked with the gut microbiome in headlines. This chapter takes them one at a time: what is established about each condition, what microbiome research has added, whether that came from mice or from people, and what a gastroenterologist can do for the gut symptoms that come with them. It offers no microbiome treatment for any of them, because none has been shown to work.

On this page In short How to read this Parkinson’s disease Alzheimer’s disease Multiple sclerosis Autism Common threads Claims to doubt What is not known When to see a doctor Questions

In short

How should I read research on gut bacteria and the brain?

With four questions. They come from chapter 4, and they matter more here than anywhere, because families facing these conditions are offered a great deal.

Four questions for any headline1Mice, or people?the striking results are mostly in mice2Who was the comparison group?housemates and twins are fairerthan unrelated volunteers3Could something else explain it?medicines, diet, constipation4Has a trial changed the outcome?a difference in stool is not a treatment

Four questions. Ask them of any headline that links gut bacteria with a brain condition.

What is known about the gut in Parkinson’s disease?

What is established first. Parkinson’s becomes commoner with age, and inherited factors play a part. A review of long-term studies found higher risk with exposure to pesticides and with head injury, and lower risk in people who are physically active. Smokers and coffee drinkers also develop it less often. That is an observation and no reason to smoke.

The gut is involved early. This is the best-supported link between the gut and any brain condition.

Years before the tremormore than ten years, in someConstipationMovementsymptomsAbout twice the later risknine studies pooledMost people with constipationnever develop Parkinson's disease

Years before. Constipation can come more than a decade before the movement symptoms. Constipation is common, and Parkinson’s is not.

It is not known whether constipation is an early part of the disease or a marker of something that leads to it. Constipation is very common, and most people who have it will never develop Parkinson’s.

Does the disease travel along the vagus nerve? Two national studies looked at people whose vagus nerve had been cut during stomach surgery. In Denmark, those whose nerve was fully cut had about half the risk of Parkinson’s after 20 years. In Sweden, the operation as a whole made no difference, with a hint of lower risk after a full cut. Both estimates were imprecise. The idea is plausible and not settled.

In mice. Mice bred to overproduce the protein that builds up in Parkinson’s developed movement problems only when they had gut bacteria. Bacteria from people with Parkinson’s made the mice worse than bacteria from healthy people. These are mice.

In people. A study of 72 people with Parkinson’s and 72 without found one family of gut bacteria much reduced. A later re-analysis of ten such studies found that the differences were consistent and small. Two cautions apply. Parkinson’s medicines have their own effect on gut bacteria. And constipation changes stool bacteria by itself.

Two further findings are worth knowing. Gut bacteria can break down the main Parkinson’s medicine before it is absorbed, shown in the laboratory. And in insurance records of 144,018 people with inflammatory bowel disease, Parkinson’s was 28% more common than in people without. Both are leads for research.

Have trials of faecal transplant helped? Three randomised trials gave three answers.

Faecal transplant in Parkinson's: three trialsChina: 56 people, by mouthoverall symptom score improved moreFinland: 45 people, one doseno meaningful difference;more gut side effectsBelgium: 46 people, one dosemovement score a little betterat 12 monthsbetter than placebono better than placebo

Three trials, three answers. Faecal transplant is not a treatment for Parkinson’s disease.

Faecal transplant is not a treatment for Parkinson’s. See faecal transplant, phages and what is coming.

What a gastroenterologist can help with. Constipation, above all. In a trial of 72 people with Parkinson’s and constipation, four weeks of a multi-strain probiotic gave about one more bowel movement a week than placebo. That is relief of constipation, not treatment of Parkinson’s. Fluids, fibre, movement, a review of medicines and laxatives where needed remain the base. Difficulty swallowing, a slow stomach and weight loss also deserve attention. See constipation and slow stomach emptying.

What is known about gut bacteria and Alzheimer’s disease?

What is established first. Age is the strongest risk, and inherited factors matter. A commission of experts lists fourteen risks that can be changed, and estimates that close to half of dementia might in theory be avoided if all were removed.

Dementia: fourteen risks that can be changedLess educationDiabetesHearing lossExcess alcoholHigh blood pressureHead injurySmokingAir pollutionObesitySocial isolationDepressionHigh LDL cholesterolPhysical inactivityUntreated vision lossGut bacteria are not on this list.From an expert commission, 2024.

Fourteen risks that can be changed. Gut bacteria are not on the list.

A trial has tested this approach. In Finland, 1,260 people aged 60 to 77 who were at higher risk were given either two years of guided diet, exercise, memory training and control of blood pressure and other vascular risks, or general health advice. Scores on tests of thinking improved a little more in the guided group. This was not a microbiome trial.

What microbiome research adds.

No trial has shown that changing gut bacteria prevents dementia or slows it.

What a gastroenterologist can help with. Constipation, poor appetite, weight loss and difficulty swallowing are common as dementia advances, and each can be eased.

What is known about gut bacteria and multiple sclerosis?

What is established first. A review lists infection with Epstein-Barr virus, smoking, low vitamin D from little sun, and obesity in adolescence, together with female sex and inherited immune genes. The virus stands out. Among more than 10 million young adults in military service, 955 developed MS, and the risk rose 32-fold after infection with this virus and not after other viruses.

What microbiome research adds. MS research shows how much the answer depends on the comparison group.

Multiple sclerosis: four ways to comparePatients and unrelated volunteerssome bacteria differed; so didtreated and untreated patientsPatients and their housemates576 pairs: some species differedIdentical twins, one with MS34 pairs: no major difference overallThe twins' stool, given to micemore mice fell ill with theaffected twin's bacteriaThe comparison group shapes the answer.

Four designs. The comparison group shapes the answer.

So there is a signal, it is modest, and medicines are part of it. No microbiome treatment for MS has been established.

What a gastroenterologist can help with. Bowel problems are very common in MS. Constipation and leakage of stool can occur in the same person. The causes include the nerve pathways themselves, several medicines taken together, and difficulty in reaching a toilet. A review advises starting with daily habits and a regular bowel routine, and moving on to biofeedback or irrigation of the bowel through the anus if those fail. Treating the bowel well improves quality of life and reduces urinary infections.

What is known about gut bacteria and autism?

Autism is a difference in development, not a disease of the gut.

What is established first. Autism is largely inherited. In a study of 2 million people in five countries, about 80% of the variation was explained by inherited factors. Vaccines are not linked with autism. Five cohort studies covering 1,256,407 children found no association.

Gut symptoms are real and common.

What microbiome research adds.

Autism, diet and gut bacteriaRestricted interestsA narrower dietLess varied gut bacteriaand looser stoolsalmostno directlinkA study of 247 children. The narrow diet explainedthe difference in gut bacteria.

Which way the arrow points. In the largest careful study, a narrow diet explained the difference in gut bacteria.

What trials have tried.

A restrictive diet has a cost in a child who already eats few foods. Calcium and protein are the nutrients most at risk.

What a gastroenterologist can help with. The gut problem deserves assessment and treatment in its own right. Constipation, reflux and abdominal pain are treated as in any child. A child who cannot describe pain may show it as a change in behaviour or sleep. Coeliac disease should be tested for before gluten is removed, because the test is unreliable afterwards. A dietitian can widen a narrow diet gradually. A urine organic acids test does not diagnose autism.

What do the four conditions have in common?

Which claims should I doubt?

See your microbiome test report.

What is not known?

From my practice

I see people with Parkinson’s disease and multiple sclerosis for constipation, swallowing and nutrition, and I work alongside their neurologist. Relieving a bowel that has been troublesome for years is worth doing for its own sake.

I do not offer faecal transplant, and I do not advise it for these conditions outside a clinical trial. I do not order stool microbiome tests to judge anyone’s risk of a brain condition. For autistic children with gut symptoms, I advise that a paediatric team assesses and treats the gut problem as it would in any child.

What this page saysHow it is known
Infrequent bowel movements went with 2.7 times the later risk of Parkinson’s6,790 men followed for 24 years
Constipation about doubled the later riskNine studies pooled
A fully cut vagus nerve went with lower riskTwo national register studies, which partly disagree
Gut bacteria were needed for movement problemsMice
Stool differences in Parkinson’s are consistent and smallA re-analysis of ten studies
Faecal transplant in Parkinson’s gave three different resultsThree randomised trials of 45 to 56 people
A probiotic eased constipation in Parkinson’sA randomised trial in 72 people
Fourteen risks for dementia can be changedAn expert commission
Diet, exercise and vascular care improved thinking scores a littleA randomised trial in 1,260 people
Without bacteria, amyloid deposits were far fewerMice
Epstein-Barr virus raised the risk of MS 32-foldA study of over 10 million young adults
Identical twins with and without MS had similar gut bacteria34 twin pairs
A narrow diet explained gut bacteria differences in autismA study of 247 children
A transfer of gut bacteria was followed by improvement18 children, with no comparison group
Gluten-free, casein-free diets did not change autismSix randomised trials, 143 participants

When should I see a doctor?

See a neurologist for a new tremor, slowness, stiffness, loss of memory that affects daily life, loss of vision, numbness or weakness. See a paediatrician for concerns about a child’s development. See a gastroenterologist for constipation that does not settle, difficulty swallowing, weight loss, blood in the stool or leakage of stool, whatever other condition is present.

Questions patients ask me

I have constipation. Will I get Parkinson’s disease?

Almost certainly not. Constipation is very common and Parkinson’s is not. The studies show a higher risk across large groups. They do not predict what will happen to one person.

Can a stool test show my risk of dementia?

No. No stool test can diagnose or predict dementia, Parkinson’s disease, multiple sclerosis or autism.

Can a probiotic slow Parkinson’s or Alzheimer’s disease?

That has not been shown. In one trial a probiotic eased constipation in people with Parkinson’s, which is useful and is a different thing.

Should my autistic child go gluten-free and casein-free?

The trials found no benefit for autism, and the diet can narrow an already limited range of foods. If your child has gut symptoms, have them assessed first, including a test for coeliac disease before any gluten is removed.

Is faecal transplant available for these conditions?

Not as treatment. Trials in Parkinson’s disagree, and for the other three conditions there is no controlled evidence that it helps. I do not perform it at present.

Is there anything I can do for my brain through my gut?

Eat well, stay active and treat constipation. These are sound for many reasons. None has been proven to prevent a brain condition through gut bacteria.

Sources

This page is written for patients and is based on the guidelines and studies below. It is for education and does not replace a consultation.

  1. Review of risk factors for Parkinson’s disease. Ascherio A, Schwarzschild MA. Lancet Neurol. 2016. doi:10.1016/S1474-4422(16)30230-7
  2. Study of bowel movement frequency and later Parkinson’s disease in 6,790 men over 24 years. Abbott RD et al. Neurology. 2001. doi:10.1212/wnl.57.3.456
  3. Meta-analysis of constipation before a diagnosis of Parkinson’s disease. Adams-Carr KL et al. J Neurol Neurosurg Psychiatry. 2016. doi:10.1136/jnnp-2015-311680
  4. Danish register study of vagotomy and later Parkinson’s disease. Svensson E et al. Ann Neurol. 2015. doi:10.1002/ana.24448
  5. Swedish register study of vagotomy and later Parkinson’s disease. Liu B et al. Neurology. 2017. doi:10.1212/WNL.0000000000003961
  6. Mouse study showing gut bacteria are needed for movement problems in a model of Parkinson’s disease. Sampson TR et al. Cell. 2016. doi:10.1016/j.cell.2016.11.018
  7. Study of gut bacteria in 72 people with Parkinson’s disease and 72 without. Scheperjans F et al. Mov Disord. 2015. doi:10.1002/mds.26069
  8. Re-analysis of ten studies of gut bacteria in Parkinson’s disease. Romano S et al. NPJ Parkinsons Dis. 2021. doi:10.1038/s41531-021-00156-z
  9. Study separating the effects of Parkinson’s disease and of its medicines on gut bacteria. Hill-Burns EM et al. Mov Disord. 2017. doi:10.1002/mds.26942
  10. Laboratory study of gut bacteria that break down the main Parkinson’s medicine. Maini Rekdal V et al. Science. 2019. doi:10.1126/science.aau6323
  11. Cohort study of inflammatory bowel disease and later Parkinson’s disease. Peter I et al. JAMA Neurol. 2018. doi:10.1001/jamaneurol.2018.0605
  12. Randomised placebo-controlled trial of oral faecal transplant in 56 people with Parkinson’s disease. Cheng Y et al. Gut Microbes. 2023. doi:10.1080/19490976.2023.2284247
  13. Randomised placebo-controlled trial of faecal transplant by colonoscopy in Parkinson’s disease. Scheperjans F et al. JAMA Neurol. 2024. doi:10.1001/jamaneurol.2024.2305
  14. Randomised trial of donor against own stool in 46 people with early Parkinson’s disease. Bruggeman A et al. EClinicalMedicine. 2024. doi:10.1016/j.eclinm.2024.102563
  15. Randomised placebo-controlled trial of a probiotic for constipation in 72 people with Parkinson’s disease. Tan AH et al. Neurology. 2021. doi:10.1212/WNL.0000000000010998
  16. Report of an expert commission on dementia prevention, intervention and care. Livingston G et al. Lancet. 2024. doi:10.1016/S0140-6736(24)01296-0
  17. Randomised trial of diet, exercise, cognitive training and vascular care in 1,260 older people at risk. Ngandu T et al. Lancet. 2015. doi:10.1016/S0140-6736(15)60461-5
  18. Study of gut bacteria in people with and without Alzheimer’s dementia. Vogt NM et al. Sci Rep. 2017. doi:10.1038/s41598-017-13601-y
  19. Study of amyloid deposits in Alzheimer’s-model mice raised without bacteria. Harach T et al. Sci Rep. 2017. doi:10.1038/srep41802
  20. Review of genetic, lifestyle and environmental risk factors for multiple sclerosis. Olsson T et al. Nat Rev Neurol. 2017. doi:10.1038/nrneurol.2016.187
  21. Study of Epstein-Barr virus infection and multiple sclerosis in over 10 million young adults. Bjornevik K et al. Science. 2022. doi:10.1126/science.abj8222
  22. Study of gut bacteria in 60 people with multiple sclerosis and 43 without. Jangi S et al. Nat Commun. 2016. doi:10.1038/ncomms12015
  23. Study of gut bacteria from 71 untreated people with multiple sclerosis and 71 controls, with mouse experiments. Cekanaviciute E et al. Proc Natl Acad Sci U S A. 2017. doi:10.1073/pnas.1711235114
  24. Study of gut bacteria in 34 identical twin pairs of whom one had multiple sclerosis, with mouse experiments. Berer K et al. Proc Natl Acad Sci U S A. 2017. doi:10.1073/pnas.1711233114
  25. Study of gut bacteria in 576 people with multiple sclerosis and household controls. iMSMS Consortium. Cell. 2022. doi:10.1016/j.cell.2022.08.021
  26. Review of bowel problems in multiple sclerosis and their management. Preziosi G et al. Degener Neurol Neuromuscul Dis. 2018. doi:10.2147/DNND.S138835
  27. Study of inherited and environmental factors in autism in 2 million people in five countries. Bai D et al. JAMA Psychiatry. 2019. doi:10.1001/jamapsychiatry.2019.1411
  28. Meta-analysis of vaccines and autism in cohort and case-control studies. Taylor LE et al. Vaccine. 2014. doi:10.1016/j.vaccine.2014.04.085
  29. Meta-analysis of gut symptoms in autistic children. McElhanon BO et al. Pediatrics. 2014. doi:10.1542/peds.2013-3995
  30. Meta-analysis of feeding problems and nutrient intake in autistic children. Sharp WG et al. J Autism Dev Disord. 2013. doi:10.1007/s10803-013-1771-5
  31. Study of autism, diet and gut bacteria in 247 children. Yap CX et al. Cell. 2021. doi:10.1016/j.cell.2021.10.015
  32. Study giving gut bacteria from autistic donors to mice raised without bacteria. Sharon G et al. Cell. 2019. doi:10.1016/j.cell.2019.05.004
  33. Open-label study of a transfer of gut bacteria in 18 autistic children. Kang DW et al. Microbiome. 2017. doi:10.1186/s40168-016-0225-7
  34. Pilot randomised placebo-controlled trial of a probiotic in autistic children. Mazzone L et al. Cell Host Microbe. 2024. doi:10.1016/j.chom.2023.11.021
  35. Meta-analysis of six randomised trials of a gluten-free, casein-free diet in autistic children. Keller A et al. Nutrients. 2021. doi:10.3390/nu13020470
  36. Double-blind challenge trial of gluten and casein in 14 autistic children. Hyman SL et al. J Autism Dev Disord. 2016. doi:10.1007/s10803-015-2564-9

Have a question about your own symptoms?

An article can explain a condition. It cannot examine you. Bring your reports and your questions to a consultation at Arka Anugraha Hospital, JP Nagar, Bengaluru.

Book on WhatsApp+91 80737 37505